Search results
Results from the WOW.Com Content Network
Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific .
Mundipharma International Limited is a British multinational research-based pharmaceutical company owned by members of the Sackler family with locations in United Kingdom, Canada, Germany, and Singapore. [2] In Germany, Mundipharma is a subsidiary of Mundipharma International Limited and Mundipharma AG.
Tuas Biomedical Park (abbreviation: TBP) is a biomedical manufacturing cluster developed by JTC Corporation at the western end of Singapore. The 183-hectare Tuas Biomedical Park I and 188-hectare Tuas Biomedical Park II are located at Tuas View – 20 minutes away from Jurong Port and five minutes from the Tuas Checkpoint to Malaysia.
In February 2015, AMRI acquired SSCI based in West Lafayette, Indiana. SSCI was founded in 1991, providing comprehensive cGMP solid state chemistry research and analytical services to the pharmaceutical industry. Servicing more than 250 customers a year. [25] [26] In July 2015, the company acquired Gadea Pharmaceutical group for $174 million. [27]
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland.
Etizolam tablets manufactured by Intas.. The company was founded by a Jain pharmacist Hasmukh Chudgar in 1977 [5] and was incorporated in 1985. [6]In 2013, ChrysCapital acquired 16.14% stake in the company, and in 2015, ChrysCapital subsequently sold 10.13% to Singapore-based Temasek Holdings [7] and in 2017, it further diluted 3.01% stake to Capital International.
Ferring Pharmaceuticals is a Swiss multinational biopharmaceutical company specialising in areas such as reproductive health, maternal health, gastroenterology and urology. [1] Ferring has been developing treatments for mothers and babies for over 50 years.